Losartan Potassium 50 mg tablets recalled due to azido impurity
RemedyRepack Inc. is recalling Losartan Potassium 50 mg tablets due to CGMP deviations with azido impurity levels above acceptable limits. The affected lots were distributed to customers in Alaska and Pennsylvania.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall due to azido impurity levels exceeding acceptable limits. Although no illnesses or injuries have been reported, azido compounds represent a potential toxicological hazard, making this a risk-of-harm product.
Plain-English summary
RemedyRepack Inc. is recalling Losartan Potassium 50 mg tablets due to Good Manufacturing Practice (CGMP) deviations. The FDA identified azido impurity levels in the affected lots that exceed acceptable limits.
The affected product includes Losartan Potassium 50 mg tablets manufactured by Lupin Pharma in two package sizes: 30-count blister cards (NDC# 70518-3282-1) and 60-count blister cards (NDC# 70518-3282-0). The affected lots are B1467803-120621 (expiring June 30, 2022) and J0585793-121721 (expiring December 31, 2022). The product was distributed to customers in Alaska and Pennsylvania.
Patients currently taking this medication should contact their healthcare provider or pharmacist to determine if they received an affected lot. Do not stop taking your medication without medical advice. Return any affected product to your pharmacy.
The recalled product
- Product
- Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug
- Hazard
- cgmp-deviation
- azido-impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # B1467803-120621
- exp. date 06/30/2022 Lot # J0585793-121721
- exp. date 12/31/2022
Distribution
Distributed in 2 states:
- AK
- PA
Related recalls
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22